Multi-directional polydentate ligands for metal-organic hybrid structures

US10562845B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10562845-B2
Application numberUS-201716085525-A
CountryUS
Kind codeB2
Filing dateJul 28, 2017
Priority dateJul 29, 2016
Publication dateFeb 18, 2020
Grant dateFeb 18, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A compound represented by Chemical Formula 1 according to the present invention can coordinate with metal ions to form a bidirectional or multidirectional metal-organic hybrid structure. Thus, the present invention can synthesize various ligands using amine-aldehyde condensation, and synthesize metal-organic materials using the same.

First claim

Opening claim text (preview).

The invention claimed is: 1. A compound represented by the following Chemical Formula 1, or a salt thereof: in the Chemical Formula 1, each R is independently —R 1 , —NH—CO—R 2 , or —NH—R 2 , each R 1 is independently —OH, a C 6-60 aryl, a C 1-10 alkyl, or an amino acid residue, and each R 2 is a C 1-10 alkyl, a C 6-60 aryl, or a C 4-60 heteroaryl containing one of N, O, and S. 2. The compound according to claim 1 , wherein each R 1 is independently —OH, phenyl, naphthyl, methyl, ethyl, propyl, isopropyl, butyl, isobutyl, tert-butyl, pentyl, tert-pentyl, neopentyl, isopentyl, sec-pentyl, 3-pentyl, or an amino acid residue selected from the group consisting of alanine, cysteine, aspartic acid, glutamic acid, phenylalanine, histidine, isoleucine, lysine, leucine, methionine, asparagine, pyrrolysine, glutamine, arginine, serine, threonine, selenocysteine, valine, tryptophan, and tyrosine. 3. The compound according to claim 1 , wherein each R 2 is independently methyl, ethyl, propyl, isopropyl, butyl, isobutyl, tert-butyl, pentyl, tert-pentyl, neopentyl, isopentyl, sec-pentyl, 3-pentyl, hexyl, octyl, phenyl, naphthyl, or pyridinyl. 4. The compound according to claim 1 , wherein the compound represented by Chemical Formula 1 is a compound represented by one of the following Chemical Formulas 1-1 to 1-5: 5. A method for preparing a compound represented by the following Chemical Formula 1 comprising the steps of: 1) reacting a compound represented by the following Chemical Formula 1′, a compound represented by the following Chemical Formula 2′ and trifluoroacetic acid to prepare a compound represented by the following Chemical Formula 3; and 2) reacting the compound represented by the following Chemical Formula 3′ with a compound represented by the following Chemical Formula 4′: in the Chemical Formulas 1 and 4′, each R is independently —R 1 , —NH—CO—R 2 , or —NH—R 2 , each R 1 is independently —OH, a C 6-60 aryl, a C 1-10 alkyl, or an amino acid residue, and each R 2 is a C 1-10 alkyl, a C 6-60 aryl, or a C 4-60 heteroaryl containing one of N, O, and S. 6. The compound according to claim 5 , wherein each R 1 is independently —OH, phenyl, naphthyl, methyl, ethyl, propyl, isopropyl, butyl, isobutyl, tert-butyl, pentyl, tert-pentyl, neopentyl, isopentyl, sec-pentyl, 3-pentyl, or an amino acid residue selected from the group consisting of alanine, cysteine, aspartic acid, glutamic acid, phenylalanine, histidine, isoleucine, lysine, leucine, methionine, asparagine, pyrrolysine, glutamine, arginine, serine, threonine, selenocysteine, valine, tryptophan, and tyrosine. 7. The compound according to claim 5 , wherein each R 2 is independently methyl, ethyl, propyl, isopropyl, butyl, isobutyl, tert-butyl, pentyl, tert-pentyl, neopentyl, isopentyl, sec-pentyl, 3-pentyl, hexyl, octyl, phenyl, naphthyl, or pyridinyl. 8. The compound according to claim 5 , wherein the compound represented by Chemical Formula 1 is a compound represented by one of the following Chemical Formulas 1-1 to 1-5:

Assignees

Inventors

Classifications

  • Two nitrogen atoms · CPC title

  • C07D251/24Primary

    to three ring carbon atoms · CPC title

  • with the carbon atom of at least one of the oxyimino groups bound to a carbon atom of a six-membered aromatic ring · CPC title

  • containing three or more hetero rings · CPC title

  • Zirconium · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10562845B2 cover?
A compound represented by Chemical Formula 1 according to the present invention can coordinate with metal ions to form a bidirectional or multidirectional metal-organic hybrid structure. Thus, the present invention can synthesize various ligands using amine-aldehyde condensation, and synthesize metal-organic materials using the same.
Who is the assignee on this patent?
Lg Chemical Ltd, Seoul Nat Univ R&Db Foundation
What technology area does this patent fall under?
Primary CPC classification C07D251/24. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Feb 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).